Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.
Cancer Res. 1988 Dec 15;48(24 Pt 1):6992-8.
The vast majority of tumor infiltrating lymphocytes (TIL) are either CD4+ or CD8+ T-lymphocytes. In order to examine directly the functional capabilities of the individual CD4+ and CD8+ TIL subsets we performed cell sorting of double immunofluorescence-labeled TIL recovered from 15 biopsies by enzyme digestion. These CD4+ and CD8+ TIL subsets were compared with similar subsets of T-lymphocytes from peripheral blood of normal subjects. Both CD4+ and CD8+ TIL showed a reduced clonogenicity as assessed quantitatively by limiting dilution analysis in a microculture system which allows every normal T-lymphocyte to undergo clonal expansion. The reduced clonogenic potential was unequally distributed among the CD4+ and CD8+ subsets with the CD8+ TIL showing a significant reduction of the frequency of proliferating T-lymphocyte precursors compared to the CD4+ TIL (with a median of 1/50 proliferating T-lymphocytes in CD8+ TIL versus a median of 1/11 in CD4+ TIL). The reduced response of CD8+ TIL was not caused by suppressor cells, lack of surface expression of CD2 and CD3 antigens nor of the alpha, beta T-cell receptor, nor by an accumulation of CD8+ cells of large granular lymphocyte morphology. Using low density cultures, the highly purified CD4+ and CD8+ TIL were stimulated either via the T-cell receptor or the CD2-mediated antigen-independent pathway of activation. Whereas CD8+ TIL did not respond to either stimulus the CD4+ TIL showed evidence of responder and nonresponder groups. In addition, we show that the deficient response obtained by triggering CD4+ TIL via the TCR can be restored by activation of the antigen-independent pathway. Finally, a total of 94 clones from four different TIL samples were obtained by limiting dilution and examined for their respective helper and cytolytic capabilities: 57% of the CD4+ TIL clones were able to produce interleukin 2 and 93% of the CD8+ TIL clones demonstrated cytolytic activity mediated by the T-cell receptor complex, indicating that the functional potential of proliferating TIL is intact.
绝大多数肿瘤浸润淋巴细胞(TIL)为CD4⁺或CD8⁺T淋巴细胞。为了直接检测单个CD4⁺和CD8⁺TIL亚群的功能能力,我们对通过酶消化从15份活检组织中回收的双免疫荧光标记的TIL进行了细胞分选。将这些CD4⁺和CD8⁺TIL亚群与正常受试者外周血中类似的T淋巴细胞亚群进行比较。在微培养系统中通过有限稀释分析进行定量评估时,CD4⁺和CD8⁺TIL均显示出克隆形成能力降低,该微培养系统可使每个正常T淋巴细胞进行克隆扩增。克隆形成潜力的降低在CD4⁺和CD8⁺亚群中分布不均,与CD4⁺TIL相比,CD8⁺TIL显示增殖性T淋巴细胞前体频率显著降低(CD8⁺TIL中增殖性T淋巴细胞的中位数为1/50,而CD4⁺TIL中为1/11)。CD8⁺TIL反应降低并非由抑制细胞、CD2和CD3抗原的表面表达缺失、α、βT细胞受体的缺失,也不是由大颗粒淋巴细胞形态的CD8⁺细胞积累所致。使用低密度培养,通过T细胞受体或CD2介导的抗原非依赖性激活途径刺激高度纯化的CD4⁺和CD8⁺TIL。虽然CD8⁺TIL对任何一种刺激均无反应,但CD4⁺TIL显示出反应者和无反应者组的证据。此外,我们表明,通过TCR触发CD4⁺TIL获得的缺陷反应可通过抗原非依赖性途径的激活得以恢复。最后,通过有限稀释从四个不同的TIL样本中总共获得了94个克隆,并检测了它们各自的辅助和细胞溶解能力:57%的CD4⁺TIL克隆能够产生白细胞介素2,93%的CD8⁺TIL克隆表现出由T细胞受体复合物介导的细胞溶解活性,表明增殖性TIL的功能潜力是完整的。